CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:CRY
- CUSIP: 22890310
- Web: www.cryolife.com
Capitalization:- Market Cap: $635.47 million
- Outstanding Shares: 33,446,000
Average Prices:- 50 Day Moving Avg: $19.18
- 200 Day Moving Avg: $17.98
- 52 Week Range: $14.02 - $20.30
P/E:- Trailing P/E Ratio: 57.73
- Foreward P/E Ratio: 46.46
- P/E Growth: 1.47
Sales & Book Value:- Annual Revenue: $183.16 million
- Price / Sales: 3.48
- Book Value: $6.56 per share
- Price / Book: 2.90
Profitability:- EBIDTA: $23.56 million
- Net Margins: 6.16%
- Return on Equity: 7.41%
- Return on Assets: 4.95%
Debt:- Debt-to-Equity Ratio: 0.30%
- Current Ratio: 5.91%
- Quick Ratio: 4.88%
Misc:- Average Volume: 112,453 shs.
- Beta: 0.97
- Short Ratio: 4.16
Frequently Asked Questions for CryoLife (NYSE:CRY)
What is CryoLife's stock symbol?
CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."
How were CryoLife's earnings last quarter?
CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings results on Monday, July, 24th. The company reported $0.12 EPS for the quarter, beating the Zacks' consensus estimate of $0.10 by $0.02. The company had revenue of $47.80 million for the quarter, compared to analysts' expectations of $47.02 million. CryoLife had a net margin of 6.16% and a return on equity of 7.41%. CryoLife's revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.13 EPS. View CryoLife's Earnings History.
When will CryoLife make its next earnings announcement?
What guidance has CryoLife issued on next quarter's earnings?
CryoLife issued an update on its FY17 earnings guidance on Monday, July, 24th. The company provided earnings per share guidance of $40-0.43 for the period, compared to the Thomson Reuters consensus estimate of $0.43. The company issued revenue guidance of $188-192 million, compared to the consensus revenue estimate of $189.31 million.
Where is CryoLife's stock going? Where will CryoLife's stock price be in 2017?
3 equities research analysts have issued 1-year price objectives for CryoLife's shares. Their forecasts range from $20.00 to $23.50. On average, they expect CryoLife's stock price to reach $22.33 in the next year. View Analyst Ratings for CryoLife.
Who are some of CryoLife's key competitors?
Some companies that are related to CryoLife include OraSure Technologies (OSUR), K2M Group Holdings (KTWO), Cardiovascular Systems (CSII), Asante Solutions (PUMP), Intersect ENT (XENT), Orthofix International N.V. (OFIX), AtriCure (ATRC), Meridian Bioscience (VIVO), Landauer (LDR), Consort Medical plc (CSRT), Antares Pharma (ATRS), STAAR Surgical Company (STAA), Invacare Corporation (IVC), Exactech (EXAC), Utah Medical Products (UTMD), Sientra (SIEN), Ocular Therapeutix (OCUL) and SeaSpine Holdings Corporation (SPNE).
Who are CryoLife's key executives?
CryoLife's management team includes the folowing people:
- James Patrick Mackin, Chairman of the Board, President, Chief Executive Officer
- D. Ashley Lee CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President
- James M McDermid, Chief Human Resource Officer
- John Davis, Senior Vice President - Global Sales and Marketing
- William Matthews, Senior Vice President - Operations, Quality, and Regulatory
- Amy D. Horton CPA, Chief Accounting Officer
- Jean F. Holloway, Chief Compliance Officer, Vice President, General Counsel, Secretary
- Scott B. Capps, Vice President - Clinical Research
- David C. Gale Ph.D., Vice President - Research & Development
- James Bullock, Director
Who owns CryoLife stock?
CryoLife's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Capital Research Global Investors (8.54%), Dimensional Fund Advisors LP (5.86%), Vanguard Group Inc. (4.96%), Macquarie Group Ltd. (4.15%), Northern Trust Corp (3.50%) and State Street Corp (2.27%). Company insiders that own CryoLife stock include Amy Horton, C Elkins Ronald, David Ashley Lee, James Benson, James P Mackin, Ronald D Mccall and Scott B Capps. View Institutional Ownership Trends for CryoLife.
Who sold CryoLife stock? Who is selling CryoLife stock?
CryoLife's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Goldman Sachs Group Inc., Royal Bank of Canada, Alliancebernstein L.P., Candriam Luxembourg S.C.A., TIAA CREF Investment Management LLC, California State Teachers Retirement System and Public Sector Pension investment Board. Company insiders that have sold CryoLife stock in the last year include Amy Horton and Scott B Capps. View Insider Buying and Selling for CryoLife.
Who bought CryoLife stock? Who is buying CryoLife stock?
CryoLife's stock was bought by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Macquarie Group Ltd., Dimensional Fund Advisors LP, Vanguard Group Inc., Thomson Horstmann & Bryant Inc., Northern Trust Corp, Marshall Wace North America L.P. and Parametric Portfolio Associates LLC. View Insider Buying and Selling for CryoLife.
How do I buy CryoLife stock?
Shares of CryoLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CryoLife's stock price today?
One share of CryoLife stock can currently be purchased for approximately $19.05.
MarketBeat Community Rating for CryoLife (NYSE CRY)MarketBeat's community ratings are surveys of what our community members think about CryoLife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for CryoLife (NYSE:CRY)Earnings History by Quarter for CryoLife (NYSE CRY)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/24/2017 | | $0.11 | | | | | N/A |  |
| 7/24/2017 | Q2 2017 | $0.10 | $0.12 | $47.02 million | $47.80 million | View | N/A | |
| 4/26/2017 | Q1 2017 | $0.04 | $0.09 | $44.64 million | $45.10 million | View | N/A | |
| 2/15/2017 | Q416 | $0.09 | $0.12 | $46.92 million | $45.00 million | View | Listen | |
| 10/26/2016 | Q316 | $0.05 | $0.13 | $44.90 million | $45.30 million | View | Listen | |
| 7/25/2016 | Q216 | $0.02 | $0.13 | $35.50 million | $47.10 million | View | Listen | |
| 4/27/2016 | Q116 | $0.02 | $0.10 | $40.50 million | $43.00 million | View | Listen | |
| 2/15/2016 | Q415 | $0.05 | $0.13 | $40.04 million | $39.80 million | View | Listen | |
| 10/27/2015 | Q315 | $0.01 | $0.10 | $38.17 million | $36.70 million | View | Listen | |
| 7/28/2015 | Q215 | | $0.03 | $35.57 million | $35.50 million | View | Listen | |
| 4/28/2015 | Q115 | $0.01 | ($0.01) | $36.55 million | $33.80 million | View | Listen | |
| 2/17/2015 | Q414 | $0.05 | $0.04 | $37.42 million | $37.20 million | View | Listen | |
| 10/28/2014 | Q314 | $0.05 | $0.08 | $37.70 million | $37.10 million | View | Listen | |
| 7/24/2014 | Q214 | $0.05 | $0.08 | $35.72 million | $34.69 million | View | Listen | |
| 4/29/2014 | Q114 | $0.07 | $0.04 | $37.30 million | $35.73 million | View | Listen | |
| 2/20/2014 | Q413 | $0.35 | $0.31 | $34.90 million | $35.50 million | View | Listen | |
| 10/29/2013 | Q313 | $0.05 | $0.12 | $35.51 million | $36.30 million | View | Listen | |
| 7/25/2013 | Q2 2013 | $0.07 | $0.08 | $35.63 million | $33.50 million | View | Listen | |
| 4/30/2013 | Q1 2013 | $0.07 | $0.08 | $35.04 million | $35.50 million | View | Listen | |
| 2/14/2013 | Q4 2012 | $0.05 | $0.08 | $33.58 million | $32.80 million | View | Listen | |
| 10/30/2012 | Q312 | $0.04 | $0.08 | $32.45 million | $33.40 million | View | N/A | |
| 7/31/2012 | | $0.05 | $0.10 | | | View | N/A | |
| 4/26/2012 | | $0.05 | $0.04 | | | View | N/A | |
| 2/16/2012 | | $0.06 | $0.07 | | | View | N/A | |
| 10/27/2011 | | $0.08 | $0.07 | | | View | N/A | |
| 7/28/2011 | | $0.06 | $0.12 | | | View | N/A | |
| 4/28/2011 | | $0.08 | $0.09 | | | View | N/A | |
| 2/17/2011 | | $0.07 | $0.08 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for CryoLife (NYSE:CRY)2017 EPS Consensus Estimate: $0.28
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.04 | $0.06 | $0.05 |
| Q2 2017 | 2 | $0.07 | $0.07 | $0.07 |
| Q3 2017 | 2 | $0.06 | $0.07 | $0.07 |
| Q4 2017 | 2 | $0.09 | $0.10 | $0.10 |
| Q1 2018 | 1 | $0.07 | $0.07 | $0.07 |
| Q2 2018 | 1 | $0.10 | $0.10 | $0.10 |
(Data provided by Zacks Investment Research)
Current Dividend Information for CryoLife (NYSE:CRY)| Most Recent Dividend: | 12/18/2015 |
| Dividend Yield: | 0.00% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio: | 0.00% (Trailing 12 Months of Earnings)
0.00% (Based on This Year's Estimates)
0.00% (Based on Next Year's Estimates)
|
| Track Record: | 4 Years of Consecutive Dividend Growth |
Dividend History by Quarter for CryoLife (NYSE CRY)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 10/22/2015 | quarterly | $0.03 | 1.22% | 12/9/2015 | 12/11/2015 | 12/18/2015 |
| 7/22/2015 | quarterly | $0.03 | 1.07% | 9/9/2015 | 9/11/2015 | 9/18/2015 |
| 5/21/2015 | quarterly | $0.03 | 1.08% | 6/10/2015 | 6/12/2015 | 6/19/2015 |
| 2/13/2015 | quarterly | $0.03 | 1.12% | 3/11/2015 | 3/13/2015 | 3/20/2015 |
| 10/23/2014 | quarterly | $0.03 | 1.14% | 12/10/2014 | 12/12/2014 | 12/19/2014 |
| 7/30/2014 | quarterly | $0.03 | 1.22% | 9/10/2014 | 9/12/2014 | 9/19/2014 |
| 5/22/2014 | quarterly | $0.03 | 1.38% | 6/11/2014 | 6/13/2014 | 6/20/2014 |
| 2/19/2014 | quarterly | $0.03 | 1.17% | 3/12/2014 | 3/14/2014 | 3/21/2014 |
| 11/21/2013 | quarterly | $0.03 | 1.05% | 12/11/2013 | 12/13/2013 | 12/20/2013 |
| 8/21/2013 | quarterly | $0.03 | 1.72% | 9/11/2013 | 9/13/2013 | 9/20/2013 |
| 5/28/2013 | quarterly | $0.03 | 1.75% | 6/12/2013 | 6/14/2013 | 6/21/2013 |
| 2/13/2013 | quarterly | $0.03 | 1.61% | 3/12/2013 | 3/14/2013 | 3/21/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for CryoLife (NYSE:CRY)Insider Ownership Percentage: 6.00%
Institutional Ownership Percentage: 69.22%
Insider Trades by Quarter for CryoLife (NYSE:CRY)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/27/2017 | Amy Horton | VP | Sell | 9,577 | $20.00 | $191,540.00 | |
| 2/22/2017 | Scott B Capps | VP | Sell | 11,083 | $16.40 | $181,761.20 | |
| 7/26/2016 | C Elkins Ronald | Director | Sell | 2,000 | $14.00 | $28,000.00 | |
| 6/1/2016 | Ronald D Mccall | Director | Sell | 10,000 | $11.56 | $115,600.00 | |
| 5/10/2016 | James Benson | Director | Sell | 5,000 | $12.22 | $61,100.00 | |
| 4/15/2016 | C Elkins Ronald | Director | Sell | 1,000 | $12.00 | $12,000.00 | |
| 3/7/2016 | C Elkins Ronald | Director | Sell | 2,000 | $11.18 | $22,360.00 | |
| 3/4/2016 | James P Mackin | CEO | Buy | 10,000 | $10.91 | $109,100.00 | |
| 2/19/2016 | Scott B Capps | VP | Sell | 15,000 | $10.30 | $154,500.00 | |
| 2/18/2016 | David Ashley Lee | CFO | Sell | 8,000 | $10.13 | $81,040.00 | |
| 12/28/2015 | David Ashley Lee | CFO | Sell | 700 | $11.00 | $7,700.00 | |
| 11/30/2015 | David Ashley Lee | CFO | Sell | 11,800 | $11.03 | $130,154.00 | |
| 9/15/2015 | James Benson | Director | Sell | 5,839 | $9.65 | $56,346.35 | |
| 9/11/2015 | James Benson | Director | Sell | 3,359 | $9.65 | $32,414.35 | |
| 2/19/2015 | Steven G Anderson | Chairman | Sell | 30,000 | $10.93 | $327,900.00 | |
| 12/9/2014 | Bruce G Anderson | VP | Sell | 3,900 | $10.29 | $40,131.00 | |
| 11/25/2014 | Bruce G Anderson | VP | Sell | 20,211 | $10.11 | $204,333.21 | |
| 11/5/2014 | C Elkins Ronald | Director | Sell | 4,000 | $10.08 | $40,320.00 | |
| 11/3/2014 | James Benson | Director | Sell | 10,000 | $10.22 | $102,200.00 | |
| 9/8/2014 | Bruce G Anderson | VP | Sell | 10,000 | $10.05 | $100,500.00 | |
| 9/2/2014 | Steven G Anderson | Chairman | Sell | 20,000 | $10.08 | $201,600.00 | |
| 8/25/2014 | Bruce G Anderson | VP | Sell | 5,000 | $10.05 | $50,250.00 | |
| 8/18/2014 | Bruce G Anderson | VP | Sell | 10,000 | $10.52 | $105,200.00 | |
| 8/14/2014 | David Ashley Lee | CFO | Sell | 10,000 | $10.51 | $105,100.00 | |
| 8/13/2014 | David Ashley Lee | CFO | Sell | 9,881 | $10.51 | $103,849.31 | |
| 8/13/2014 | Jeffrey W Burris | VP | Sell | 11,000 | $10.50 | $115,500.00 | |
| 7/29/2014 | C Elkins Ronald | Director | Sell | 2,500 | $9.67 | $24,175.00 | |
| 7/28/2014 | Bruce G Anderson | VP | Sell | 5,000 | $9.48 | $47,400.00 | |
| 7/28/2014 | Steven G Anderson | CEO | Sell | 19,477 | $9.52 | $185,421.04 | |
| 6/9/2014 | Amy Horton | CAO | Sell | 2,500 | $9.26 | $23,150.00 | |
| 5/16/2014 | David Fronk | VP | Sell | 8,952 | $8.61 | $77,076.72 | |
| 5/13/2014 | Steven Anderson | CEO | Sell | 30,523 | $9.00 | $274,707.00 | |
| 5/6/2014 | Bruce Anderson | VP | Sell | 16,870 | $8.83 | $148,962.10 | |
| 11/26/2013 | Jeffrey Burris | VP | Sell | 5,000 | $10.50 | $52,500.00 | |
| 11/11/2013 | Jeffrey Burris | VP | Sell | 5,000 | $10.00 | $50,000.00 | |
| 11/7/2013 | Steven Anderson | CEO | Sell | 100,000 | $9.38 | $938,000.00 | |
| 10/29/2013 | C Elkins Ronald | Director | Sell | 2,000 | $9.00 | $18,000.00 | |
| 10/29/2013 | Jeffrey W Burris | VP | Sell | 5,000 | $9.00 | $45,000.00 | |
| 8/27/2013 | Bruce Anderson | VP | Sell | 4,500 | $6.33 | $28,485.00 | |
| 8/8/2013 | Amy Horton | CAO | Sell | 2,500 | $7.07 | $17,675.00 | |
| 8/1/2013 | Ronald D Mccall | Director | Sell | 6,000 | $7.10 | $42,600.00 | |
| 6/6/2013 | Ronald D Mccall | Director | Sell | 4,000 | $6.15 | $24,600.00 | |
| 5/31/2013 | C Elkins Ronald | Director | Sell | 2,250 | $6.15 | $13,837.50 | |
(Data available from 1/1/2013 forward)
Headline Trends for CryoLife (NYSE:CRY)
Latest Headlines for CryoLife (NYSE:CRY)
| Source: |
|
| Date | Headline |
|---|
 | Zacks Investment Research Upgrades CryoLife, Inc. (NYSE:CRY) to Hold
www.americanbankingnews.com - August 14 at 7:56 PM |
 | ETFs with exposure to CryoLife, Inc. : August 14, 2017
finance.yahoo.com - August 14 at 5:56 PM |
| ETFs with exposure to CryoLife, Inc. : August 4, 2017
finance.yahoo.com - August 4 at 12:00 AM |
| Zacks Investment Research Lowers CryoLife, Inc. (CRY) to Sell
www.americanbankingnews.com - August 2 at 9:34 PM |
| CryoLife to Present at 37th Annual Canaccord Genuity Growth Conference
finance.yahoo.com - August 2 at 6:23 PM |
| CryoLife, Inc. to Post FY2017 Earnings of $0.31 Per Share, First Analysis Forecasts (NYSE:CRY)
www.americanbankingnews.com - August 2 at 10:38 AM |
| Ecolab (ECL) Beats Earnings and Revenue Estimates in Q2
finance.yahoo.com - August 1 at 6:16 PM |
| Brokers Offer Predictions for CryoLife, Inc.'s Q3 2017 Earnings (NYSE:CRY)
www.americanbankingnews.com - August 1 at 8:02 AM |
| CryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : July 28, 2017
finance.yahoo.com - July 29 at 4:52 PM |
| CryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2017 By the Numbers : July 26, 2017
finance.yahoo.com - July 26 at 6:07 PM |
| Edited Transcript of CRY earnings conference call or presentation 25-Jul-17 12:00pm GMT
finance.yahoo.com - July 25 at 10:40 PM |
| Investor Network: CryoLife, Inc. to Host Earnings Call
finance.yahoo.com - July 25 at 5:34 PM |
| CryoLife posts 2Q profit
finance.yahoo.com - July 24 at 10:17 PM |
| CryoLife, Inc. (NYSE:CRY) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - July 24 at 9:14 PM |
| CryoLife, Inc. (NYSE:CRY) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - July 24 at 6:50 PM |
| CryoLife, Inc. (CRY) Updates FY17 Earnings Guidance
www.americanbankingnews.com - July 24 at 5:25 PM |
| CryoLife Reports Second Quarter 2017 Financial Results
finance.yahoo.com - July 24 at 5:13 PM |
| Stryker Poised on Solid Product Portfolio and Acquisitions
finance.yahoo.com - July 18 at 7:04 PM |
| CryoLife, Inc. (NYSE:CRY) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - July 17 at 8:52 AM |
 | McKesson (MCK) Poised on Improving Generic and Brand Market
www.zacks.com - July 13 at 6:47 PM |
| Fresenius Medical (FMS) Well Poised on Growth Strategy 2020
finance.yahoo.com - July 12 at 6:15 PM |
| Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked
finance.yahoo.com - July 12 at 6:15 PM |
| AmerisourceBergen's PharMEDium Slows Down, Competition Rife
www.zacks.com - July 11 at 11:41 PM |
 | Heart Valve Devices Market 13.35% CAGR by 2021 With TAVR and TMVR Says a Research Report Available at ReportsnReports
www.marketwatch.com - July 11 at 11:41 PM |
| AmerisourceBergen's PharMEDium Slows Down, Competition Rife
finance.yahoo.com - July 11 at 6:39 PM |
| CryoLife Announces Release Date and Teleconference Call Details for 2017 Second Quarter Financial Results
finance.yahoo.com - July 10 at 5:31 PM |
| Amy Horton Sells 9,577 Shares of CryoLife, Inc. (CRY) Stock
www.americanbankingnews.com - June 29 at 10:32 AM |
 | CryoLife Hits a 52-Week High: What's Driving the Stock?
www.nasdaq.com - June 28 at 5:28 PM |
| Varian Rides on Oncology and Proton Therapy Businesses
finance.yahoo.com - June 28 at 5:28 PM |
| CryoLife Hits a 52-Week High: What's Driving the Stock?
finance.yahoo.com - June 28 at 5:28 PM |
| Quintiles' (Q) OCE Software to Simplify Commercial Functions
finance.yahoo.com - June 27 at 4:49 PM |
| ETFs with exposure to CryoLife, Inc. : June 26, 2017
finance.yahoo.com - June 26 at 5:20 PM |
| Luminex (LMNX) Banks on Portfolio Strength, View Impressive
finance.yahoo.com - June 22 at 10:41 AM |
| Cryolife Inc (CRY) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - June 8 at 7:12 PM |
| Cryolife Inc (CRY) Forecasted to Earn Q1 2018 Earnings of $0.07 Per Share
www.americanbankingnews.com - June 7 at 9:14 AM |
| ETFs with exposure to CryoLife, Inc. : June 6, 2017
finance.yahoo.com - June 6 at 4:44 PM |
| First Analysis Weighs in on Cryolife Inc's Q2 2017 Earnings (CRY)
www.americanbankingnews.com - June 6 at 7:08 AM |
| Prosthetic Heart Valve/Artificial Heart Valve Market Worth 8.86 Billion USD by 2022
www.marketwatch.com - June 5 at 12:02 PM |
| Cryolife Inc (CRY) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 29 at 11:08 PM |
| ETFs with exposure to CryoLife, Inc. : May 22, 2017
finance.yahoo.com - May 22 at 4:20 PM |
| C. R. Bard, Inc. (BCR)
finance.yahoo.com - May 14 at 4:36 PM |
| ETFs with exposure to CryoLife, Inc. : May 8, 2017
finance.yahoo.com - May 8 at 9:23 PM |
| Cryolife (CRY) Receives Daily News Impact Rating of 0.03
www.americanbankingnews.com - May 3 at 3:05 PM |
| Cryolife Inc (CRY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 3 at 12:34 AM |
| CryoLife, Inc. :CRY-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 4:27 PM |
| Cryolife (CRY) Receives News Sentiment Score of 0.32
www.americanbankingnews.com - April 29 at 9:35 PM |
| CryoLife, Inc. – Value Analysis (NYSE:CRY) : April 28, 2017
finance.yahoo.com - April 28 at 5:29 PM |
| Cryolife Inc (CRY) Earns "Buy" Rating from Northland Securities
www.americanbankingnews.com - April 28 at 2:58 PM |
| CryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : April 27, 2017
finance.yahoo.com - April 28 at 3:06 AM |
| Edited Transcript of CRY earnings conference call or presentation 27-Apr-17 12:00pm GMT
finance.yahoo.com - April 28 at 3:06 AM |
CryoLife (CRY) Chart for Saturday, August, 19, 2017
